Home   >  

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

GPCR/G Protein

Chemical Structure Cat. No. Product Name CAS No.
BD1063 dhydrochloride Chemical Structure
BCP31637 BD1063 dhydrochloride 206996-13-6
BD1063 dhydrochloride is a potent and selective sigma 1 receptor antagonist.
ZT-12-037-01 Chemical Structure
BCP31626 ZT-12-037-01 2328073-61-4
ZT-12-037-01 is a potent, selective, ATP-competitive STK19 inhibitor. ZT-12-037-01 effectively blocks oncogenic NRAS-driven melanocyte malignant transformation and melanoma growth in vitro and in vivo.
Imetit Dihydrobromide Chemical Structure
BCP31622 Imetit Dihydrobromide 32385-58-3
Imetit Dihydrobromide is a histamine H3 receptor (H3R) agonist.
Centhaquine Chemical Structure
BCP31600 Centhaquine 57961-90-7
Centhaquine is an adrenergic receptor potentially for the treatment of postoperative pain and for the resuscitation of hypovolemic shock.
JDTic Chemical Structure
BCP31607 JDTic 361444-66-8
JDTic is a highly selective antagonist for the κ-opioid receptor; without affecting the μ- or δ-opioid receptors.
THIQ Chemical Structure
BCP31597 THIQ 312637-48-2
THIQ is a potent and selective melanocortin 4 receptor agonist (2,3) (IC50= 1.2, 761 and 2067 nM for human MC4, MC3 and MC1 receptors respectively).
GLP-1 receptor agonist 5 Chemical Structure
BCP31389 GLP-1 receptor agonist 5 1246826-07-2
GLP-1 receptor agonist 5 is a GLP-1 receptor agonist extracted from patent WO2010114824A1, Example 179, with an EC50 of 5 nM.
JNJ-54175446 Chemical Structure
BCP31541 JNJ-54175446 1627902-21-9
JNJ-54175446 is a potent and selective brain penetrant P2X7 receptor antagonist, with pIC50s of 8.46 and 8.81 for hP2X7 receptor and rP2X7 receptor, respectively.
BI-2852 Chemical Structure
BCP31539 BI-2852 BI-2852
BI-2852 is a KRAS inhibitor for the switch I/II pocket (SI/II-pocket) by structure-based drug design with nanomolar affinity.
MRTX849 Chemical Structure
BCP31538 MRTX849 2326521-71-3
MRTX849 is a potent, orally-available, and mutation-selective covalent inhibitor of KRAS G12C with potential antineoplastic activity. MRTX849 covalently binds to KRAS G12C at the cysteine at residue 12, locks the protein in its inactive GDP-bound conformation, and inhibits KRAS-dependent signal transduction.
123下一页末页共 1487 条记录 1 / 149 页 
0086-15971444841